Myelodysplasia

• Virginia Commonwealth University

  1 trialPhase 261 people

• St. Jude Children's Research Hospital

  1 trialPhase 240 people

• Indiana University

  1 trialPhase 229 people

National Heart, Lung, and Blood InstituteUS$500.1k2 grants since 2023

• Identifying mis-splicing-derived antigens in spliceosomal mutant myelodysplasia and targeting via T-cell receptor therapeutics

  National Heart, Lung, and Blood InstituteWeill Medical Coll of Cornell UnivUS$55.1k2024–2027

• Molecular mechanisms of splicing dependency in cohesin-mutant myelodysplasia

  National Heart, Lung, and Blood InstituteDana-farber Cancer InstUS$445k2023–2028